Login / Signup

Determining the optimal timing of adjuvant chemotherapy initiation after concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma.

H ChengJ ChenG JiaY LiangY LiY ChenJ LinP WangQ ChenL TangH MaiL Liu
Published in: ESMO open (2024)
The optimal timing of AC initiation is ∼37 days after concurrent chemoradiotherapy in patients with locoregionally advanced nasopharyngeal carcinoma. A delay beyond 69.5 days is associated with compromised survival. Efforts should be made to address the reasons for delays and ensure the timely initiation of AC.
Keyphrases
  • locally advanced
  • rectal cancer
  • squamous cell carcinoma
  • radiation therapy
  • free survival